BioIntelligence GmbH

Name

BioIntelligence GmbH

Legal name

BioIntelligence GmbH

Website

https://bio-intelligence.eu

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Biotech Incubator Services

NAICS

Professional and Management Development Training (611430), Professional and Management Development Training (61143)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

akta.pro secondary industry

Entrepreneurship Foundations & Startup Basics (EDAMAHAA)

Keywords

• Biotech startup incubator
• Life science accelerator
• Medtech innovation hub
• Startup funding grants
• Corporate innovation consulting

Headquarters

HQ city

Hanover

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Government Funding: BioIntelligence operates as a government-funded high-tech incubator. Funding is secured from the Lower Saxony Ministry of Economic Affairs through NBank until end of 2028. The organization provides grants of up to €300,000 to qualifying startups through the HTI (Hightech Inkubatoren/Akzeleratoren) program.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

BioIntelligence GmbH operates a high-tech incubator and innovation hub for biotech, medtech, and life science startups. It runs a 12-month HTI BioIntelligence incubator program (up to 10 startups per batch) providing qualifying startups with grants of up to €300,000, alongside mentoring, workshops, networking, and coaching. Beyond startup support, it offers consulting services to life science startups and innovation services for corporates, plus talent matching between startups and specialists.

Product overview

BioIntelligence GmbH operates as a high-tech incubator and innovation hub for life science startups in Hanover, Germany. The core offering is the HTI BioIntelligence Incubator Program providing funding (up to €300,000), networking, mentoring, coaching, workshops, and focus days to early-stage biotech, medtech, and life sciences companies. The portfolio includes 24 startups across three batches developing AI-powered solutions (Alera mental health platform, GOENOMICS mendle® search engine, Daklintec Dakura nutrition therapy, ELPIS Simulation StroQ stroke prediction), medical devices (Biomarq Health biosensor, Lifelight Health drug delivery, SmartCast orthoses), therapeutic platforms (Allogenetics, TOLERAGEN, GliTTHer, NeuroXR CyberFul), biotech innovations (NanoDrug Delivery, InCapSolution, Phaeosynt, Plantilizer), and sustainable food technology (Plandelicious, myotwin heart tissue platform). Supporting services include BioIntelligence Consulting for Start-ups and Innovation for Corporates connecting industry partners with startups.

Differentiator

Problem solved

Functional benefit

Products and services

• HTI BioIntelligence Incubator Program A 12-month cohort-based incubator program for early-stage biotech, medtech and life science startups, providing qualifying startups with non-dilutive grants of up to €300,000, structured workshops, individualized mentoring, coaching, and access to a curated network of experts, investors and industry partners.
• BioIntelligence Consulting for Start-ups Advisory and consulting services tailored to life science startups, covering business model validation, fundraising preparation, investor readiness, and operational mentoring delivered through the BioIntelligence team and expert network.
• BioIntelligence Innovation for Corporates Corporate innovation service through which BioIntelligence connects pharmaceutical, medtech, chemical and life science corporates with vetted portfolio startups for open innovation, pilot projects, and partnership opportunities.

Quantifiable outcome

• 14 startups successfully supported in first batch (2023) with pre-seed funding up to €200,000
• +2 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Partnerships

Ten partnerships are on record, tiered core, major and supporting.

• BioDigit e.V.coreStrategic or Co-development Partner · 1 January 2018BioDigit e.V. is the non-profit association (founded 2018) that is the mother organization and founder of BioIntelligence GmbH. The association consists of partners from science and business working at the intersection of biotechnology and digital innovation. BioDigit provides the strategic direction and idea generation for the incubator, focused on sustainability and the bioeconomy.
• Leibniz Universität HannovercoreStrategic or Co-development PartnerTop-tier German research university (TU9) and excellent network partner. With strong emphasis on innovation and technology transfer, LUH provides startups with access to groundbreaking research and resources. The Institute for Innovation Research, Technology Management & Entrepreneurship (ITE) is the founding partner and idea provider for the incubator.
• Volkswagen FoundationmajorStrategic or Co-development PartnerDr. Georg Schütte, Secretary General of Volkswagen Foundation since 2020, serves on the HTI BioIntelligence Steering Committee, providing strategic guidance and connecting the incubator with funding opportunities.
• Ottobock SE & Co. KGaAmajorStrategic or Co-development PartnerMartin Böhm, Chief Experience Officer at Ottobock, serves on the BioIntelligence Steering Committee/Board. Ottobock is a medtech company providing industry perspective and connections for startups in the medical technology space.
• TÜV NORD GROUPmajorStrategic or Co-development PartnerDr. Dietmar Schloesser, Director of Digitalization & Innovation at TÜV NORD GROUP, serves on the Advisory Board, supporting startups with expertise in building scalable business models and digital transformation.
• innos GmbHcoreStrategic or Co-development Partnerinnos GmbH is a consulting and project management company. André Kaufung serves as CEO of innos GmbH and also as Managing Director of BioIntelligence. Several team members (Felina Kallbach, Ulrike Munz, Marie Schmidt) work at both organizations, creating operational synergies.
• Hafven GmbH & Co. KGmajorStrategic or Co-development PartnerHafven is a major coworking community in Lower Saxony with approximately 1,000 active members. One of the largest coworking communities in the German-speaking region, offering innovation programs including Impact Accelerator, providing physical workspace and ecosystem connections for startups.
• GÖRG Partnerschaft von Rechtsanwälten mbBsupportingImplementation/ SI/ Consulting PartnerGÖRG is a law firm providing advisory services. Partners Dr. Jan-Henric Punte (Corporate Law, M&A, VC/PE), Dr. Oliver Jauch (Public Procurement Law), and Rolf-Alexander Markgraf (Employment Law) advise startups on company formation, restructuring, director liability, procurement, and HR matters.
• VOSSIUSsupportingImplementation/ SI/ Consulting PartnerVOSSIUS is a patent and trademark law firm. Partners Dr. Florian Grasser (IP, biotech, life sciences) and Arnold Asmussen (Patents, MedTech, engineering) advise startups on intellectual property protection, due diligence, freedom-to-operate assessments, and patent filings.
• BRAIN Biotech AGmajorStrategic or Co-development PartnerDr. Jürgen Eck, Co-Founder of BRAIN AG (now listed company) and Co-CEO & CTO of SymbioGruppe, serves on the Advisory Board, contributing extensive experience in industrial biotechnology and sustainable product development.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Life Science Inkubator (LSI) Bonn: German publicly-funded life science incubator in Bonn under a similar HTI-style model. Directly comparable: supports early-stage biotech/medtech startups with funding, mentoring, and infrastructure, and operates with public funding from NRW.
• High-Tech Gründerfonds (HTGF): Germany's leading early-stage tech investor providing seed funding to high-tech startups. Comparable as a publicly-backed funding vehicle for science-based startups, though HTGF is a fund (equity) rather than an operating incubator.
• BIH Innovation (Charité): Berlin Institute of Health's innovation arm supporting translation of academic research into spinouts. Comparable in bridging academic life science research with startup formation, though geographically Berlin rather than Lower Saxony.
• MassChallenge HealthTech: Global non-profit accelerator supporting healthcare and life science startups with mentoring, corporates, and grant funding. Comparable as a non-profit, cohort-based, equity-free life science accelerator.
• IndieBio (SOSV): Global biotech accelerator providing funding, lab space, and mentorship to science-driven startups. Comparable as a life science-focused accelerator, though takes equity and is not regionally constrained to Germany.
• Creative Destruction Lab (CDL): Non-profit program for science-based startups including a dedicated CDL Bio stream. Comparable in cohort-based, mentor-driven approach for deep-tech and biotech founders; equity-free and global.

Broad incumbents

• Bayer CoLaborator: Bayer's life science incubator in Berlin providing lab space and mentorship to early-stage biotech/medtech startups. Comparable in target founders and life science focus, but corporate-operated and not government-funded.
• Techstars Startup Programs: Global accelerator network with mentor-driven, cohort-based programs. Comparable in operating model (3-month programs, mentoring, demo day), though Techstars is sector-agnostic and equity-taking.

Regional players

• BioRN Network e.V. Leading life science cluster in the Rhine-Neckar region organizing ecosystem programs for biotech startups and corporates. Comparable as a regional life science innovation hub, though primarily a cluster association rather than an operating incubator.
• EMBL Enterprise Management Technology Transfer (EMBLEM): EMBL's technology transfer arm supporting spinouts from European molecular biology research. Comparable as an academic-anchored life science commercialization vehicle, though focused on EMBL IP rather than open applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biointelligence-gmbh
• Instagraminstagram.com/bio_intelligence_eu

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioIntelligence GmbH